The common inflammatory condition sinusitis is linked to a 40% heightened risk of a subsequent diagnosis of rheumatic disease, particularly in the five to 10 years preceding the start of symptoms, according to research published ...
Feb 27, 2024
0
6
The American Academy of Otolaryngology–Head and Neck Surgery Foundation has published the Clinical Practice Guideline: Immunotherapy for Inhalant Allergy in Otolaryngology–Head and Neck Surgery. This clinical practice ...
Feb 26, 2024
0
0
Researchers at Karolinska Institutet have discovered a link between a rare and severe form of psoriatic arthritis and an enzyme that produces oxygen radicals. The study, published in the journal EMBO Molecular Medicine, reveals ...
Feb 26, 2024
0
1
Just weeks after news of a sharp national spike in asthma deaths—with South Australia recording the highest increase in a single year (88%)—scientists have revealed a promising new treatment for the chronic lung disease.
Feb 26, 2024
0
0
A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of ...
Feb 25, 2024
0
50
An overly robust immune response to usually harmless germs has been linked to colitis, a potentially severe inflammation of the colon that afflicts millions of people worldwide. A new Yale-led study not only reveals that ...
Feb 22, 2024
0
58
You've probably seen recent claims online seed oils are "toxic" and cause inflammation, cancer, diabetes and heart disease. But what does the research say?
Feb 21, 2024
0
2
Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.
Feb 21, 2024
0
0
Researchers have identified how cells work to resolve frozen shoulder, opening up potential new targets for treatment and reducing the need for surgery.
Feb 19, 2024
0
25
Academic researchers from King's College London have investigated the early effects of an immunosuppressant drug that could help clinicians with future personalized approaches for the treatment of psoriasis.
Feb 19, 2024
0
19
